J. Scott Wolchko - Aug 19, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Aug 19, 2021
Transactions value $
-$1,663,504
Form type
4
Date filed
8/20/2021, 04:02 PM
Previous filing
Jul 26, 2021
Next filing
Oct 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $96.7K +20K +5.08% $4.84 414K Aug 19, 2021 Direct F1
transaction FATE Common Stock Sale -$1.76M -20K -4.83% $88.01* 394K Aug 19, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -20K -80.5% $0.00 4.85K Aug 19, 2021 Common Stock 20K $4.84 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
F2 This option is fully vested.